ETHOSUXIMIDE

ETHOSUXIMIDE was reported 2522 times

ETHOSUXIMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENZODIAZEPINE DRUG LEVEL DECREASED 7 0.4667
1 JEAVONS SYNDROME 2 0.4000
2 AUTOIMMUNE APLASTIC ANAEMIA 4 0.2857
3 CARNITINE ABNORMAL 2 0.2500
4 ANTIMITOCHONDRIAL ANTIBODY 2 0.2500
5 ATYPICAL ABSENCE SEIZURE 1 0.2500
6 CONGENITAL CORNEAL ANOMALY 1 0.1667
7 BENIGN ROLANDIC EPILEPSY 4 0.1429
8 BRONCHIAL ASPIRATION PROCEDURE 2 0.1111
9 CAMPTODACTYLY ACQUIRED 1 0.0909
10 OROPHARYNGEAL OEDEMA 13 0.0897
11 ABDOMINAL WALL CYST 10 0.0820
12 CSF PROTEIN DECREASED 1 0.0667
13 OCULOCEPHALOGYRIC REFLEX ABSENT 3 0.0566
14 COMA BLISTER 5 0.0556
15 BLEPHAROPHIMOSIS 1 0.0526
16 DYSPROSODY 1 0.0526
17 PSYCHOMOTOR DISADAPTATION SYNDROME 2 0.0488
18 CONGENITAL NIPPLE ANOMALY 1 0.0476
19 DRUG METABOLISING ENZYME TEST ABNORMAL 1 0.0476
20 DEVELOPMENTAL REGRESSION 6 0.0441
21 CSWS SYNDROME 1 0.0435
22 BILE OUTPUT DECREASED 1 0.0435
23 BARBITURATES POSITIVE 3 0.0375
24 ACQUIRED MACROGLOSSIA 3 0.0337
25 MULTIPLE-DRUG RESISTANCE 104 0.0335
26 OPSOCLONUS MYOCLONUS 7 0.0329
27 MYOCLONIC EPILEPSY 49 0.0323
28 HYPERANDROGENISM 3 0.0319
29 INTENTION TREMOR 18 0.0317
30 GENERALISED NON-CONVULSIVE EPILEPSY 1 0.0303
31 ATONIC SEIZURES 25 0.0291
32 PLAGIOCEPHALY 14 0.0281
33 AUTOMATISM EPILEPTIC 1 0.0278
34 BODY DYSMORPHIC DISORDER 10 0.0267
35 SWEAT GLAND DISORDER 11 0.0262
36 PYLORIC STENOSIS 21 0.0248
37 VESICOURETERIC REFLUX 10 0.0247
38 ANAL ATRESIA 13 0.0243
39 INTELLECTUAL DISABILITY 36 0.0237
40 PETIT MAL EPILEPSY 120 0.0235
41 TONIC CONVULSION 33 0.0233
42 REYE'S SYNDROME 2 0.0220
43 TRACHEO-OESOPHAGEAL FISTULA 13 0.0203
44 SCLERODERMA-LIKE REACTION 3 0.0190
45 POLYSEROSITIS 8 0.0188
46 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 3 0.0186
47 MACROGLOSSIA 10 0.0182
48 EPIPHYSES DELAYED FUSION 1 0.0182
49 DROPPED HEAD SYNDROME 7 0.0177
50 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 13 0.0173
51 COMPLICATED FRACTURE 1 0.0161
52 BULIMIA NERVOSA 7 0.0159
53 CEREBELLAR ATROPHY 14 0.0159
54 ARACHNODACTYLY 1 0.0156
55 CONGENITAL EYELID MALFORMATION 2 0.0155
56 ADRENOGENITAL SYNDROME 2 0.0148
57 ACHLORHYDRIA 1 0.0143
58 CHANGE IN SEIZURE PRESENTATION 9 0.0139
59 CONGENITAL MUSCULOSKELETAL DISORDER OF SKULL 1 0.0139
60 HEPATIC ADENOMA 7 0.0135
61 CAMPTODACTYLY CONGENITAL 1 0.0132
62 VAGAL NERVE STIMULATOR IMPLANTATION 4 0.0131
63 SJS-TEN OVERLAP 9 0.0128
64 CLEFT LIP AND PALATE 13 0.0116
65 ANTICONVULSANT DRUG LEVEL ABNORMAL 2 0.0114
66 BENZODIAZEPINE DRUG LEVEL INCREASED 1 0.0105
67 PNEUMOCOCCAL INFECTION 6 0.0101
68 ELECTROENCEPHALOGRAM ABNORMAL 32 0.0101
69 DROP ATTACKS 6 0.0101
70 EYELID MYOCLONUS 1 0.0100
71 FOETAL VALPROATE SYNDROME 1 0.0100
72 SEIZURE CLUSTER 8 0.0097
73 PRODUCT ADMINISTRATION ISSUE 2 0.0096
74 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 1 0.0095
75 GENERALISED TONIC-CLONIC SEIZURE 153 0.0092
76 ATROPHIC GLOSSITIS 1 0.0092
77 FACIAL DYSMORPHISM 2 0.0090
78 STATUS EPILEPTICUS 102 0.0090
79 LENNOX-GASTAUT SYNDROME 2 0.0088
80 PRECOCIOUS PUBERTY 5 0.0088
81 CONGENITAL NEUROLOGICAL DISORDER 1 0.0085
82 BEHAVIOUR DISORDER 46 0.0085
83 DUPUYTREN'S CONTRACTURE 1 0.0084
84 CHOANAL ATRESIA 1 0.0083
85 APLASTIC ANAEMIA 43 0.0082
86 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
87 HYPERDYNAMIC LEFT VENTRICLE 2 0.0081
88 ANTICONVULSANT DRUG LEVEL INCREASED 13 0.0080
89 SELF-DESTRUCTIVE BEHAVIOUR 7 0.0080
90 DISSOCIATIVE AMNESIA 1 0.0077
91 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 5 0.0077
92 CONGENITAL ANOMALY IN OFFSPRING 1 0.0076
93 ENZYME LEVEL DECREASED 1 0.0076
94 HYDROCELE 8 0.0075
95 ABDOMINAL WALL INFECTION 1 0.0075
96 ALBUMIN GLOBULIN RATIO INCREASED 1 0.0073
97 POSTURAL TREMOR 2 0.0068
98 ATAXIA 80 0.0067
99 MITRAL VALVE THICKENING 2 0.0067
100 GLUCOSE URINE 1 0.0067
101 HYPOSPADIAS 12 0.0058
102 MITRAL VALVE DISEASE 10 0.0056
103 COMPLEMENT FACTOR DECREASED 1 0.0056
104 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 3 0.0056
105 DISSOCIATIVE DISORDER 4 0.0055
106 DELUSIONAL DISORDER, UNSPECIFIED TYPE 4 0.0053
107 COLOBOMA 1 0.0053
108 BRAIN STEM SYNDROME 4 0.0053
109 INFECTION REACTIVATION 6 0.0052
110 DYSSOMNIA 1 0.0052
111 HAEMANGIOMA 12 0.0052
112 ENCOPRESIS 1 0.0052
113 GRANULOCYTES ABNORMAL 1 0.0050
114 AMMONIA ABNORMAL 2 0.0050
115 ANHIDROSIS 2 0.0049
116 LOW SET EARS 2 0.0049
117 HALLUCINATION, OLFACTORY 2 0.0046
118 CONGENITAL ORAL MALFORMATION 1 0.0046
119 POLYDIPSIA 18 0.0045
120 BLOOD ETHANOL INCREASED 1 0.0045
121 LUPUS-LIKE SYNDROME 41 0.0045
122 EPILEPTIC ENCEPHALOPATHY 1 0.0045
123 PARVOVIRUS B19 INFECTION 4 0.0045
124 NEUROMA 2 0.0044
125 CHOREOATHETOSIS 3 0.0044
126 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
127 ANTICONVULSANT DRUG LEVEL DECREASED 6 0.0042
128 CLONIC CONVULSION 3 0.0041
129 DEVELOPMENTAL DELAY 37 0.0041
130 CEREBRAL ARTERY STENOSIS 2 0.0041
131 SUICIDAL BEHAVIOUR 17 0.0041
132 PHIMOSIS 3 0.0041
133 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
134 ERYTHEMA INFECTIOSUM 1 0.0039
135 COOMBS TEST POSITIVE 1 0.0037
136 EXCITABILITY 1 0.0037
137 DEJA VU 1 0.0036
138 PSEUDOLYMPHOMA 2 0.0036
139 COMPLEX PARTIAL SEIZURES 4 0.0036
140 CONGENITAL CARDIOVASCULAR ANOMALY 3 0.0036
141 EXCESSIVE SKIN 1 0.0035
142 EPILEPSY 108 0.0035
143 ENZYME LEVEL INCREASED 3 0.0035
144 GROSS MOTOR DELAY 1 0.0035
145 BONE DEVELOPMENT ABNORMAL 1 0.0035
146 FOOD INTERACTION 6 0.0034
147 REFLUX GASTRITIS 4 0.0033
148 CREATININE URINE INCREASED 1 0.0033
149 EPIPHYSES PREMATURE FUSION 1 0.0033
150 DECREASED EYE CONTACT 1 0.0033
151 DISABILITY ASSESSMENT SCALE SCORE INCREASED 1 0.0033
152 DEFIANT BEHAVIOUR 1 0.0032
153 PRODUCT APPEARANCE CONFUSION 3 0.0032
154 SEIZURE 375 0.0032
155 HYPERAMMONAEMIA 16 0.0032
156 DRUG LEVEL CHANGED 2 0.0032
157 BREAST CELLULITIS 1 0.0032
158 PRESSURE OF SPEECH 2 0.0031
159 BREAST HAEMORRHAGE 1 0.0030
160 REACTION TO EXCIPIENT 7 0.0030
161 ABDOMINOPLASTY 1 0.0030
162 AUTISM 3 0.0030
163 POSTICTAL STATE 3 0.0029
164 BRADYKINESIA 17 0.0029
165 MYOCLONUS 34 0.0028
166 HEART DISEASE CONGENITAL 10 0.0028
167 DRUG-GENETIC INTERACTION 1 0.0028
168 EXANTHEM 1 0.0028
169 MULTIPLE CONGENITAL ABNORMALITIES 4 0.0028
170 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
171 EOSINOPHILIC COLITIS 1 0.0027
172 OLIGURIA 17 0.0027
173 AMINO ACID LEVEL INCREASED 2 0.0027
174 VANISHING BILE DUCT SYNDROME 3 0.0027
175 BK VIRUS INFECTION 9 0.0027
176 CORNEAL REFLEX DECREASED 1 0.0027
177 MUCOSAL HAEMORRHAGE 3 0.0026
178 ASTROCYTOMA 1 0.0025
179 GRAND MAL CONVULSION 22 0.0024
180 AMAUROSIS 2 0.0024
181 CORONA VIRUS INFECTION 1 0.0023
182 LANGUAGE DISORDER 5 0.0023
183 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0023
184 RENAL TUBULAR ATROPHY 2 0.0023
185 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
186 ANION GAP INCREASED 3 0.0022
187 CLUMSINESS 6 0.0022
188 CHRONIC FATIGUE SYNDROME 3 0.0022
189 LUPUS NEPHRITIS 4 0.0021
190 BREAST ENLARGEMENT 7 0.0021
191 CEREBELLAR ATAXIA 2 0.0021
192 HYPERVIGILANCE 2 0.0021
193 DROWNING 2 0.0020
194 AMMONIA INCREASED 10 0.0020
195 BREAST CONSERVING SURGERY 1 0.0020
196 POLYCYSTIC OVARIES 3 0.0019
197 FLIGHT OF IDEAS 1 0.0019
198 HYPOTONIA NEONATAL 3 0.0019
199 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
200 HYPERKINESIA 4 0.0019
201 DRUG LEVEL ABNORMAL 1 0.0019
202 CONGENITAL NOSE MALFORMATION 1 0.0019
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
204 EXECUTIVE DYSFUNCTION 1 0.0018
205 BLOOD INSULIN INCREASED 1 0.0018
206 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
207 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
208 DRUG RESISTANCE 46 0.0018
209 ENCEPHALOMALACIA 1 0.0018
210 DYSPRAXIA 1 0.0018
211 APNOEIC ATTACK 1 0.0018
212 GAZE PALSY 3 0.0018
213 NEPHROTIC SYNDROME 12 0.0017
214 HYDRONEPHROSIS 13 0.0017
215 ENURESIS 7 0.0017
216 ENTERAL NUTRITION 1 0.0017
217 CHRONIC SPONTANEOUS URTICARIA 2 0.0017
218 GINGIVAL HYPERPLASIA 1 0.0017
219 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
220 DYSMETRIA 1 0.0017
221 AGGRESSION 81 0.0016
222 ACUTE PULMONARY OEDEMA 9 0.0016
223 HYPOTONIA 16 0.0016
224 LIP HAEMORRHAGE 2 0.0016
225 BODY HEIGHT BELOW NORMAL 1 0.0016
226 PROCEDURAL HAEMORRHAGE 6 0.0015
227 PARTIAL SEIZURES 8 0.0015
228 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
229 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
230 NYSTAGMUS 8 0.0015
231 LEARNING DISABILITY 8 0.0015
232 TREATMENT FAILURE 121 0.0015
233 CEREBRAL CYST 1 0.0015
234 RASH MORBILLIFORM 4 0.0014
235 NECROSIS 8 0.0014
236 IMMUNE THROMBOCYTOPENIC PURPURA 4 0.0014
237 ENCEPHALOPATHY 34 0.0014
238 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
239 APALLIC SYNDROME 1 0.0014
240 PULMONARY VALVE INCOMPETENCE 2 0.0014
241 STRIDOR 4 0.0014
242 GROWTH RETARDATION 4 0.0014
243 THORACIC VERTEBRAL FRACTURE 4 0.0014
244 HICCUPS 11 0.0013
245 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
246 BRAIN OPERATION 3 0.0013
247 EYELID DISORDER 3 0.0013
248 CONVULSION 74 0.0013
249 GRIMACING 1 0.0013
250 BREAST FEEDING 1 0.0013
251 MOTOR DYSFUNCTION 13 0.0013
252 DYSMORPHISM 3 0.0013
253 NEONATAL DISORDER 2 0.0013
254 INAPPROPRIATE AFFECT 2 0.0013
255 PATENT DUCTUS ARTERIOSUS 5 0.0013
256 DISINHIBITION 2 0.0012
257 STARING 3 0.0012
258 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
259 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
260 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
261 PRODUCT PREPARATION ISSUE 8 0.0012
262 PSYCHOTIC DISORDER 36 0.0012
263 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
264 CSF PROTEIN INCREASED 1 0.0012
265 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
266 ADRENAL SUPPRESSION 1 0.0012
267 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
268 ENTEROVIRUS INFECTION 1 0.0012
269 GINGIVAL ERYTHEMA 1 0.0012
270 CRANIOSYNOSTOSIS 1 0.0012
271 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
272 KIDNEY FIBROSIS 2 0.0012
273 AXONAL NEUROPATHY 1 0.0011
274 AFFECTIVE DISORDER 9 0.0011
275 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
276 FOOD REFUSAL 1 0.0011
277 COGNITIVE DISORDER 53 0.0011
278 DEPRESSIVE SYMPTOM 4 0.0011
279 THINKING ABNORMAL 21 0.0011
280 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
281 BLOOD ALBUMIN INCREASED 1 0.0011
282 BLEPHAROSPASM 7 0.0011
283 PRODUCT TASTE ABNORMAL 15 0.0011
284 ABNORMAL WITHDRAWAL BLEEDING 1 0.0011
285 ABULIA 1 0.0011
286 AURA 2 0.0011
287 PERFORMANCE STATUS DECREASED 5 0.0011
288 HYPERTHERMIA 8 0.0010
289 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
290 AGITATION NEONATAL 1 0.0010
291 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
292 BLOOD URINE 1 0.0010
293 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
294 EYE MOVEMENT DISORDER 7 0.0010
295 VENOUS THROMBOSIS 4 0.0010
296 VOCAL CORD DISORDER 2 0.0010
297 CEREBRAL ATROPHY 4 0.0010
298 KLEBSIELLA INFECTION 5 0.0010
299 BREAST ABSCESS 1 0.0010
300 TALIPES 3 0.0010
301 ABNORMAL BEHAVIOUR 38 0.0010
302 PETECHIAE 10 0.0010
303 LIVEDO RETICULARIS 2 0.0010
304 DILATATION VENTRICULAR 2 0.0010
305 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
306 EYE CONTUSION 2 0.0009
307 JOINT DISLOCATION 10 0.0009
308 CUSHINGOID 3 0.0009
309 FACIAL PALSY 2 0.0009
310 FOETAL MALFORMATION 1 0.0009
311 REACTION TO DRUG EXCIPIENTS 2 0.0009
312 BIPOLAR I DISORDER 2 0.0009
313 CONGENITAL ANOMALY 7 0.0009
314 PELVIC FRACTURE 7 0.0009
315 INCREASED APPETITE 17 0.0009
316 MYOCARDITIS 10 0.0009
317 DROOLING 6 0.0009
318 CEREBRAL VENTRICLE DILATATION 1 0.0009
319 BONE MARROW TOXICITY 1 0.0008
320 MYOPIA 2 0.0008
321 ENDOMETRIOSIS 4 0.0008
322 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
323 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
324 FEBRILE CONVULSION 1 0.0008
325 SOMNOLENCE 162 0.0008
326 GASTROINTESTINAL TUBE INSERTION 2 0.0008
327 TOXIC ENCEPHALOPATHY 4 0.0008
328 INCREASED BRONCHIAL SECRETION 2 0.0008
329 THERAPY PARTIAL RESPONDER 12 0.0008
330 BRADYPHRENIA 5 0.0008
331 STEVENS-JOHNSON SYNDROME 17 0.0008
332 AREFLEXIA 2 0.0007
333 IRRITABILITY 45 0.0007
334 CHEILITIS 4 0.0007
335 DRUG INTERACTION 117 0.0007
336 CALCULUS BLADDER 1 0.0007
337 CLUSTER HEADACHE 1 0.0007
338 ABNORMAL WEIGHT GAIN 9 0.0007
339 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
340 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
341 INTRACRANIAL PRESSURE INCREASED 4 0.0007
342 FANCONI SYNDROME 1 0.0007
343 CATAPLEXY 1 0.0007
344 AUDITORY DISORDER 1 0.0007
345 SALIVARY HYPERSECRETION 7 0.0007
346 TEARFULNESS 3 0.0007
347 HYPOKINESIA 10 0.0007
348 GENERALISED ANXIETY DISORDER 1 0.0007
349 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
350 EXCESSIVE EYE BLINKING 1 0.0007
351 WHEELCHAIR USER 3 0.0007
352 HERNIA 13 0.0007
353 PRODUCT ODOUR ABNORMAL 7 0.0007
354 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
355 ASTIGMATISM 1 0.0007
356 PANIC ATTACK 24 0.0007
357 JOINT INJURY 14 0.0007
358 IMMUNE THROMBOCYTOPENIA 3 0.0007
359 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
360 CALCULUS URINARY 1 0.0006
361 SEDATION 17 0.0006
362 DAYDREAMING 1 0.0006
363 LOCALISED OEDEMA 3 0.0006
364 GENERALISED OEDEMA 8 0.0006
365 POOR QUALITY DRUG ADMINISTERED 4 0.0006
366 APATHY 9 0.0006
367 HALLUCINATION, VISUAL 13 0.0006
368 THROMBOTIC MICROANGIOPATHY 6 0.0006
369 NIGHTMARE 21 0.0006
370 DRUG LEVEL INCREASED 10 0.0006
371 COLON CANCER 9 0.0006
372 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
373 FOOD AVERSION 1 0.0006
374 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
375 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
376 BLOOD PH DECREASED 1 0.0006
377 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
378 CHOREA 1 0.0006
379 PRIAPISM 2 0.0006
380 FAILURE TO THRIVE 3 0.0006
381 HYPERTRANSAMINASAEMIA 4 0.0006
382 AMENORRHOEA 10 0.0006
383 FANCONI SYNDROME ACQUIRED 1 0.0006
384 BLOOD LACTIC ACID INCREASED 3 0.0006
385 GROIN PAIN 5 0.0006
386 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
387 ANGER 19 0.0006
388 PRODUCT SUPPLY ISSUE 4 0.0006
389 FRUSTRATION 2 0.0006
390 PRODUCT SIZE ISSUE 3 0.0006
391 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
392 DECREASED ACTIVITY 6 0.0006
393 APPARENT DEATH 2 0.0006
394 PREGNANCY 11 0.0005
395 HYPERACUSIS 2 0.0005
396 THERAPY NON-RESPONDER 24 0.0005
397 BLOOD IRON INCREASED 1 0.0005
398 BLOOD BICARBONATE DECREASED 1 0.0005
399 BONE MARROW TRANSPLANT 1 0.0005
400 OSTEOPENIA 8 0.0005
401 LIPASE INCREASED 4 0.0005
402 ATROPHY 1 0.0005
403 BICYTOPENIA 1 0.0005
404 GENE MUTATION 1 0.0005
405 COORDINATION ABNORMAL 7 0.0005
406 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
407 DRUG LEVEL DECREASED 5 0.0005
408 CYTOPENIA 6 0.0005
409 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 2 0.0005
410 DYSARTHRIA 18 0.0005
411 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
412 THERAPEUTIC RESPONSE CHANGED 3 0.0005
413 DEPRESSED MOOD 25 0.0005
414 FOETAL DISTRESS SYNDROME 1 0.0005
415 SCREAMING 3 0.0005
416 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
417 IRRITABLE BOWEL SYNDROME 10 0.0005
418 DIPLOPIA 12 0.0005
419 PRODUCT PRESCRIBING ERROR 11 0.0005
420 CEREBELLAR SYNDROME 1 0.0005
421 CORNEAL DISORDER 1 0.0005
422 DYSPHEMIA 2 0.0005
423 APPETITE DISORDER 3 0.0005
424 ADVERSE REACTION 6 0.0005
425 PURPURA 4 0.0005
426 FAECES PALE 1 0.0004
427 ABORTION SPONTANEOUS 18 0.0004
428 HEPATOTOXICITY 10 0.0004
429 BACTERIAL TEST POSITIVE 1 0.0004
430 BRAIN FOG 7 0.0004
431 DISTURBANCE IN ATTENTION 24 0.0004
432 GASTRIC CANCER 11 0.0004
433 HAIR GROWTH ABNORMAL 3 0.0004
434 APHTHOUS STOMATITIS 1 0.0004
435 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
436 RETCHING 9 0.0004
437 PRE-ECLAMPSIA 2 0.0004
438 SUICIDAL IDEATION 38 0.0004
439 DERMATITIS BULLOUS 3 0.0004
440 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
441 DRUG EXPOSURE DURING PREGNANCY 14 0.0004
442 HORMONE LEVEL ABNORMAL 2 0.0004
443 PSYCHIATRIC SYMPTOM 3 0.0004
444 PARANOIA 7 0.0004
445 PRESCRIBED UNDERDOSE 8 0.0004
446 LEUKOPENIA 20 0.0004
447 FLUID INTAKE REDUCED 2 0.0004
448 BRAIN INJURY 4 0.0004
449 DERMATITIS ALLERGIC 5 0.0004
450 EXCORIATION 1 0.0004
451 DRUG INEFFECTIVE 519 0.0004
452 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
453 PHLEBITIS 2 0.0004
454 PRODUCT COLOUR ISSUE 2 0.0004
455 INCREASED UPPER AIRWAY SECRETION 2 0.0004
456 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
457 HYPOALBUMINAEMIA 3 0.0004
458 INTENTIONAL DOSE OMISSION 11 0.0004
459 FOETAL DEATH 2 0.0004
460 LETHARGY 22 0.0004
461 CATATONIA 2 0.0004
462 TRICUSPID VALVE INCOMPETENCE 3 0.0004
463 BLOOD SODIUM INCREASED 1 0.0004
464 SKIN LACERATION 4 0.0004
465 SLEEP APNOEA SYNDROME 7 0.0004
466 TIC 2 0.0004
467 MOOD ALTERED 10 0.0004
468 GINGIVAL BLEEDING 5 0.0004
469 DECREASED APPETITE 85 0.0004
470 CLONUS 1 0.0004
471 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
472 PRESCRIBED OVERDOSE 7 0.0004
473 DYSTONIA 7 0.0004
474 INTERMENSTRUAL BLEEDING 2 0.0004
475 PANCYTOPENIA 20 0.0004
476 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
477 ENDOTRACHEAL INTUBATION 1 0.0004
478 DRUG TOLERANCE DECREASED 1 0.0004
479 FACE OEDEMA 6 0.0004
480 GYNAECOMASTIA 11 0.0004
481 CONDITION AGGRAVATED 107 0.0004
482 IMPAIRED DRIVING ABILITY 4 0.0004
483 VITAMIN D DECREASED 3 0.0004
484 UNRESPONSIVE TO STIMULI 9 0.0003
485 VISUAL DISTURBANCE 2 0.0003
486 HEAD INJURY 11 0.0003
487 TREATMENT NONCOMPLIANCE 19 0.0003
488 FIBULA FRACTURE 1 0.0003
489 MOOD SWINGS 11 0.0003
490 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
491 DYSKINESIA 14 0.0003
492 METABOLIC DISORDER 2 0.0003
493 ABORTION 1 0.0003
494 DECREASED INTEREST 2 0.0003
495 DRUG ERUPTION 6 0.0003
496 BRAIN HERNIATION 1 0.0003
497 MUSCLE RIGIDITY 4 0.0003
498 WITHDRAWAL SYNDROME 14 0.0003
499 CRANIOCEREBRAL INJURY 1 0.0003
500 PRODUCT SUBSTITUTION ISSUE 19 0.0003
501 EYE INJURY 1 0.0003
502 AGITATION 24 0.0003
503 RESPIRATORY DISTRESS 9 0.0003
504 ECTOPIC PREGNANCY 1 0.0003
505 PERSONALITY CHANGE 3 0.0003
506 BLISTER 18 0.0003
507 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
508 BLOOD CREATININE DECREASED 1 0.0003
509 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
510 PRODUCT USE COMPLAINT 5 0.0003
511 ABDOMINAL ADHESIONS 1 0.0003
512 HYPERSOMNIA 9 0.0003
513 MOVEMENT DISORDER 10 0.0003
514 ANOREXIA 4 0.0003
515 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
516 MENORRHAGIA 6 0.0003
517 BEDRIDDEN 4 0.0003
518 MANIA 5 0.0003
519 MUSCLE TWITCHING 7 0.0003
520 TREMOR 50 0.0003
521 ANXIETY DISORDER 1 0.0003
522 DRUG TOXICITY 4 0.0003
523 ACUTE HEPATIC FAILURE 4 0.0003
524 RESPIRATION ABNORMAL 2 0.0003
525 MENTAL IMPAIRMENT 7 0.0003
526 DRUG-INDUCED LIVER INJURY 9 0.0003
527 SPEECH DISORDER 15 0.0003
528 BRONCHIOLITIS 1 0.0003
529 HAND FRACTURE 2 0.0003
530 HEPATOCELLULAR INJURY 4 0.0003
531 CONJUNCTIVAL HYPERAEMIA 1 0.0003
532 BODY HEIGHT DECREASED 3 0.0003
533 OFF LABEL USE 245 0.0003
534 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
535 GASTROENTERITIS VIRAL 5 0.0003
536 TONGUE DISORDER 2 0.0003
537 CRYING 10 0.0003
538 CHOLELITHIASIS 9 0.0003
539 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
540 BLOOD PHOSPHORUS DECREASED 1 0.0003
541 ANGIOEDEMA 12 0.0003
542 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
543 FOOT DEFORMITY 3 0.0003
544 HYPOPHOSPHATAEMIA 2 0.0003
545 GAIT DISTURBANCE 51 0.0003
546 CHRONIC SINUSITIS 1 0.0003
547 MITRAL VALVE INCOMPETENCE 3 0.0003
548 APHASIA 8 0.0003
549 FRACTURE 5 0.0003
550 POLLAKIURIA 11 0.0003
551 ACIDOSIS 2 0.0003
552 COMMUNICATION DISORDER 1 0.0003
553 HYPOKALAEMIA 12 0.0003
554 PERICARDIAL EFFUSION 6 0.0003
555 FOOD ALLERGY 2 0.0003
556 RASH PRURITIC 14 0.0003
557 CAESAREAN SECTION 3 0.0003
558 CHOKING 5 0.0003
559 HYPOXIA 9 0.0003
560 LYMPHADENOPATHY 9 0.0003
561 BACTERAEMIA 3 0.0003
562 LOW BIRTH WEIGHT BABY 2 0.0003
563 ACCIDENT 3 0.0003
564 HYPOTHYROIDISM 8 0.0003
565 MYELOSUPPRESSION 9 0.0002
566 TRANSPLANT REJECTION 2 0.0002
567 NERVOUSNESS 13 0.0002
568 HYPONATRAEMIA 14 0.0002
569 SENSORY LOSS 2 0.0002
570 DRUG EFFECT INCOMPLETE 9 0.0002
571 INTENTIONAL SELF-INJURY 5 0.0002
572 FRUSTRATION TOLERANCE DECREASED 2 0.0002
573 PRODUCT ADMINISTRATION ERROR 5 0.0002
574 GALLBLADDER OPERATION 1 0.0002
575 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
576 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
577 GOITRE 1 0.0002
578 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
579 SECRETION DISCHARGE 3 0.0002
580 SENSATION OF FOREIGN BODY 2 0.0002
581 AORTIC VALVE INCOMPETENCE 1 0.0002
582 MYDRIASIS 3 0.0002
583 WEIGHT INCREASED 52 0.0002
584 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
585 DRUG INTOLERANCE 22 0.0002
586 GALLBLADDER DISORDER 4 0.0002
587 RESPIRATORY FAILURE 16 0.0002
588 LUNG NEOPLASM MALIGNANT 9 0.0002
589 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
590 EAR DISORDER 1 0.0002
591 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
592 PRODUCT DISTRIBUTION ISSUE 2 0.0002
593 HEPATIC FUNCTION ABNORMAL 8 0.0002
594 SLEEP DISORDER 15 0.0002
595 BLOOD PROLACTIN INCREASED 1 0.0002
596 VOMITING 98 0.0002
597 AFFECT LABILITY 2 0.0002
598 ATELECTASIS 2 0.0002
599 FINGER DEFORMITY 1 0.0002
600 LIVER FUNCTION TEST ABNORMAL 6 0.0002
601 DIZZINESS POSTURAL 2 0.0002
602 LIVER INJURY 5 0.0002
603 HEPATOMEGALY 2 0.0002
604 INTENTIONAL OVERDOSE 13 0.0002
605 ABASIA 5 0.0002
606 LIGAMENT SPRAIN 2 0.0002
607 EXPIRED DRUG ADMINISTERED 1 0.0002
608 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
609 ABDOMINAL TENDERNESS 1 0.0002
610 UPPER LIMB FRACTURE 4 0.0002
611 DERMATITIS EXFOLIATIVE 1 0.0002
612 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
613 PRODUCT PHYSICAL ISSUE 4 0.0002
614 SUICIDE ATTEMPT 12 0.0002
615 NEPHROLITHIASIS 9 0.0002
616 INSURANCE ISSUE 3 0.0002
617 CEREBRAL ISCHAEMIA 1 0.0002
618 VENTRICULAR EXTRASYSTOLES 2 0.0002
619 CYANOSIS 3 0.0002
620 ABDOMINAL PAIN UPPER 39 0.0002
621 RESPIRATORY TRACT CONGESTION 3 0.0002
622 HALLUCINATION, AUDITORY 3 0.0002
623 OBESITY 3 0.0002
624 EAR INFECTION 5 0.0002
625 EATING DISORDER 4 0.0002
626 BREAST PAIN 2 0.0002
627 COMPRESSION FRACTURE 1 0.0002
628 POOR QUALITY SLEEP 4 0.0002
629 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
630 BIPOLAR DISORDER 2 0.0002
631 BACK INJURY 2 0.0002
632 TOXICITY TO VARIOUS AGENTS 31 0.0002
633 PALLOR 5 0.0002
634 PRODUCT PRESCRIBING ISSUE 4 0.0002
635 ASPIRATION 2 0.0002
636 FAECALOMA 1 0.0002
637 GASTROINTESTINAL PAIN 2 0.0002
638 AUTISM SPECTRUM DISORDER 1 0.0002
639 RESPIRATORY ARREST 5 0.0002
640 DENTAL CARIES 2 0.0002
641 MENTAL STATUS CHANGES 5 0.0002
642 TRANSAMINASES INCREASED 4 0.0002
643 LOSS OF CONSCIOUSNESS 23 0.0002
644 FEELING HOT 11 0.0002
645 THROMBOCYTOPENIA 20 0.0002
646 MALNUTRITION 2 0.0002
647 ANGIOPATHY 1 0.0002
648 NEPHROPATHY TOXIC 2 0.0002
649 EXPOSURE DURING PREGNANCY 11 0.0002
650 REBOUND EFFECT 2 0.0002
651 DISORIENTATION 7 0.0002
652 CIRCULATORY COLLAPSE 3 0.0002
653 GENERALISED ERYTHEMA 1 0.0002
654 CARDIAC VALVE DISEASE 1 0.0002
655 HALLUCINATION 13 0.0002
656 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
657 ELECTROLYTE IMBALANCE 2 0.0002
658 EYELID OEDEMA 2 0.0002
659 WEIGHT DECREASED 48 0.0002
660 SPLENOMEGALY 2 0.0002
661 BRADYCARDIA 9 0.0002
662 URINARY INCONTINENCE 5 0.0002
663 DYSPHAGIA 16 0.0002
664 BLOOD POTASSIUM DECREASED 5 0.0002
665 HEPATIC FAILURE 5 0.0002
666 RESTLESS LEGS SYNDROME 3 0.0002
667 THERAPEUTIC RESPONSE DECREASED 10 0.0002
668 NOCTURIA 2 0.0002
669 HYPERGLYCAEMIA 6 0.0002
670 FOETAL GROWTH RESTRICTION 1 0.0002
671 DEPRESSION 37 0.0002
672 HYPOACUSIS 7 0.0002
673 FALL 54 0.0002
674 EMOTIONAL DISORDER 5 0.0002
675 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
676 CHOLANGITIS 1 0.0002
677 PNEUMONIA ASPIRATION 4 0.0002
678 NO ADVERSE EVENT 29 0.0002
679 BLOOD SODIUM DECREASED 3 0.0002
680 BLOOD URINE PRESENT 3 0.0002
681 MUSCLE ATROPHY 2 0.0002
682 COLITIS ULCERATIVE 7 0.0002
683 DRUG PRESCRIBING ERROR 3 0.0002
684 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
685 GALACTORRHOEA 1 0.0002
686 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
687 DYSPEPSIA 15 0.0002
688 DYSGRAPHIA 1 0.0002
689 STAPHYLOCOCCAL INFECTION 5 0.0002
690 PANCREATITIS 8 0.0002
691 SPINAL FRACTURE 3 0.0001
692 JAUNDICE 4 0.0001
693 OEDEMA PERIPHERAL 18 0.0001
694 BONE MARROW FAILURE 3 0.0001
695 COMA 7 0.0001
696 ABNORMAL LOSS OF WEIGHT 1 0.0001
697 PRODUCT DOSE OMISSION ISSUE 43 0.0001
698 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
699 FATIGUE 113 0.0001
700 ENCEPHALITIS 1 0.0001
701 EXTRASYSTOLES 1 0.0001
702 LYMPHOPENIA 2 0.0001
703 RASH 61 0.0001
704 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
705 AMNESIA 9 0.0001
706 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
707 DYSSTASIA 4 0.0001
708 MIGRAINE 13 0.0001
709 CEREBRAL DISORDER 1 0.0001
710 ARTHROPOD BITE 1 0.0001
711 RASH MACULO-PAPULAR 3 0.0001
712 FEELING DRUNK 1 0.0001
713 GASTROINTESTINAL DISORDER 12 0.0001
714 EPISTAXIS 10 0.0001
715 PRODUCT USE ISSUE 25 0.0001
716 HYPERHIDROSIS 17 0.0001
717 INSOMNIA 35 0.0001
718 MEMORY IMPAIRMENT 18 0.0001
719 DRUG DISPENSING ERROR 2 0.0001
720 TINNITUS 6 0.0001
721 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
722 ADVERSE EVENT 12 0.0001
723 THYROID DISORDER 2 0.0001
724 APHTHOUS ULCER 1 0.0001
725 APNOEA 1 0.0001
726 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
727 DIZZINESS 64 0.0001
728 INJURY 9 0.0001
729 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
730 DRUG SCREEN POSITIVE 1 0.0001
731 DECUBITUS ULCER 1 0.0001
732 ALOPECIA 24 0.0001
733 MULTIPLE FRACTURES 2 0.0001
734 OSTEOPOROSIS 5 0.0001
735 FEELING ABNORMAL 29 0.0001
736 LIP SWELLING 4 0.0001
737 EOSINOPHIL COUNT INCREASED 1 0.0001
738 RHABDOMYOLYSIS 5 0.0001
739 BLOOD UREA INCREASED 2 0.0001
740 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
741 HAEMATEMESIS 3 0.0001
742 HEMIPARESIS 2 0.0001
743 RENAL FAILURE ACUTE 5 0.0001
744 HYPOPHAGIA 3 0.0001
745 MUSCULOSKELETAL DISCOMFORT 2 0.0001
746 ANURIA 1 0.0001
747 BLOOD MAGNESIUM DECREASED 1 0.0001
748 CARDIAC MURMUR 1 0.0001
749 ILL-DEFINED DISORDER 7 0.0001
750 LOCAL SWELLING 2 0.0001
751 EOSINOPHILIA 2 0.0001
752 BLOOD CALCIUM INCREASED 1 0.0001
753 GASTRITIS 3 0.0001
754 HEADACHE 71 0.0001
755 LIVER DISORDER 5 0.0001
756 FEAR 3 0.0001
757 CONFUSIONAL STATE 18 0.0001
758 ADVERSE DRUG REACTION 10 0.0001
759 ANAL INCONTINENCE 1 0.0001
760 THROAT TIGHTNESS 3 0.0001
761 ACCIDENTAL OVERDOSE 4 0.0001
762 RESTLESSNESS 4 0.0001
763 BRAIN NEOPLASM 1 0.0001
764 CONJUNCTIVITIS 2 0.0001
765 ABDOMINAL PAIN 25 0.0001
766 MIDDLE INSOMNIA 2 0.0001
767 APPENDICITIS 1 0.0001
768 DEFORMITY 1 0.0001
769 DIARRHOEA HAEMORRHAGIC 1 0.0001
770 PYREXIA 37 0.0001
771 CHOLESTASIS 2 0.0001
772 BALANCE DISORDER 9 0.0001
773 HYPOGLYCAEMIA 5 0.0001
774 AUTOIMMUNE DISORDER 1 0.0001
775 TACHYCARDIA 9 0.0001
776 SINUS DISORDER 2 0.0001
777 RESPIRATORY DISORDER 3 0.0001
778 FEEDING DISORDER 2 0.0001
779 EYELID PTOSIS 1 0.0001
780 EUPHORIC MOOD 1 0.0001
781 ROAD TRAFFIC ACCIDENT 4 0.0001
782 URTICARIA 16 0.0001
783 NAUSEA 73 0.0001
784 OEDEMA 5 0.0001
785 MENTAL DISORDER 4 0.0001
786 PRODUCT DISPENSING ERROR 2 0.0001
787 ACUTE KIDNEY INJURY 14 0.0001
788 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
789 EYE DISORDER 3 0.0001
790 VIRAL INFECTION 3 0.0001
791 DEHYDRATION 12 0.0001
792 MEDICATION ERROR 5 0.0001
793 TOOTH DISORDER 2 0.0001
794 URINARY RETENTION 3 0.0001
795 HYPOTENSION 18 0.0001
796 ORAL PAIN 2 0.0001
797 SNEEZING 2 0.0001
798 PANCREATITIS ACUTE 2 0.0001
799 BLOOD CALCIUM DECREASED 1 0.0001
800 VISUAL IMPAIRMENT 11 0.0001
801 EYE INFECTION 1 0.0001
802 ANXIETY 25 0.0001
803 ILLNESS 9 0.0001
804 PLATELET COUNT DECREASED 9 0.0001
805 DISEASE RECURRENCE 4 0.0001
806 ANAEMIA 16 0.0001
807 RASH ERYTHEMATOUS 4 0.0001
808 OVERDOSE 18 0.0001
809 RENAL IMPAIRMENT 7 0.0001
810 DIARRHOEA 53 0.0001
811 INJECTION SITE URTICARIA 2 0.0001
812 DYSURIA 3 0.0001
813 PNEUMONIA 26 0.0001
814 VISION BLURRED 11 0.0001
815 ABDOMINAL DISCOMFORT 13 0.0001
816 BACK PAIN 18 0.0001
817 HAEMATOMA 2 0.0001
818 PRODUCT DOSE OMISSION 5 0.0001
819 MUSCULOSKELETAL PAIN 4 0.0001
820 URINARY TRACT INFECTION 13 0.0001
821 HYPERTENSION 16 0.0001
822 BLOOD BILIRUBIN INCREASED 2 0.0001
823 PULMONARY EMBOLISM 7 0.0001
824 HEPATIC ENZYME INCREASED 5 0.0001
825 DEVICE MECHANICAL ISSUE 1 0.0001
826 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
827 ASTHENIA 27 0.0001
828 APHONIA 1 0.0001
829 BLOOD TEST ABNORMAL 1 0.0001
830 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
831 BLINDNESS UNILATERAL 1 0.0001
832 MALAISE 31 0.0001
833 MUSCULAR WEAKNESS 8 0.0001
834 RED BLOOD CELL COUNT DECREASED 2 0.0001
835 ACCIDENTAL UNDERDOSE 1 0.0001
836 GASTROENTERITIS 1 0.0001
837 UNDERDOSE 5 0.0001
838 COVID-19 12 0.0001
839 ASCITES 2 0.0001
840 RENAL FAILURE 9 0.0001
841 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
842 DYSGEUSIA 5 0.0001
843 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
844 THROAT IRRITATION 3 0.0001
845 BONE LOSS 1 0.0001
846 PREMATURE BABY 2 0.0001
847 INCORRECT DOSE ADMINISTERED 15 0.0001
848 VERTIGO 4 0.0001
849 SKIN DISCOLOURATION 3 0.0001
850 DRUG ADMINISTRATION ERROR 2 0.0001
851 DEVICE RELATED INFECTION 1 0.0001
852 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
853 ANKLE FRACTURE 1 0.0001
854 DELUSION 1 0.0001
855 INFLUENZA 7 0.0001
856 BLOOD POTASSIUM INCREASED 1 0.0001
857 SWELLING FACE 4 0.0001
858 BLOOD CREATININE INCREASED 4 0.0001
859 HEART RATE INCREASED 6 0.0001
860 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
861 COAGULOPATHY 1 0.0001
862 SKIN DISORDER 2 0.0001
863 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
864 PRODUCT QUALITY ISSUE 8 0.0001
865 DELIRIUM 2 0.0001
866 INTENTIONAL PRODUCT MISUSE 5 0.0001
867 COLD SWEAT 1 0.0001
868 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
869 GOUT 1 0.0001
870 DRUG EFFECT DECREASED 3 0.0001
871 OROPHARYNGEAL PAIN 5 0.0001
872 ARTHROPATHY 3 0.0001
873 AGRANULOCYTOSIS 1 0.0001
874 OXYGEN SATURATION DECREASED 3 0.0001
875 UNEVALUABLE EVENT 4 0.0001
876 FOOT FRACTURE 1 0.0001
877 EYE IRRITATION 3 0.0001
878 ACUTE RESPIRATORY FAILURE 1 0.0001
879 ERUCTATION 1 0.0001
880 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
881 NASAL CONGESTION 3 0.0001
882 DISEASE PROGRESSION 6 0.0001
883 DISABILITY 1 0.0001
884 HAEMATOCRIT DECREASED 1 0.0001
885 BLOOD PRESSURE ABNORMAL 1 0.0001
886 FULL BLOOD COUNT DECREASED 1 0.0000
887 BLINDNESS 2 0.0000
888 NEUTROPHIL COUNT DECREASED 2 0.0000
889 BODY TEMPERATURE INCREASED 1 0.0000
890 ERYTHEMA 10 0.0000
891 INFLUENZA LIKE ILLNESS 4 0.0000
892 CARDIAC ARREST 4 0.0000
893 CARDIO-RESPIRATORY ARREST 2 0.0000
894 DERMATITIS 1 0.0000
895 RECTAL HAEMORRHAGE 2 0.0000
896 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
897 PRODUCT STORAGE ERROR 4 0.0000
898 PAIN 28 0.0000
899 HOSPITALISATION 7 0.0000
900 FEBRILE NEUTROPENIA 3 0.0000
901 PARAESTHESIA 7 0.0000
902 ASTHMA 5 0.0000
903 NASOPHARYNGITIS 8 0.0000
904 CHEST PAIN 8 0.0000
905 RENAL DISORDER 2 0.0000
906 CARDIAC DISORDER 4 0.0000
907 DYSPNOEA 24 0.0000
908 OCULAR HYPERAEMIA 2 0.0000
909 NEUROPATHY PERIPHERAL 4 0.0000
910 BLOOD GLUCOSE DECREASED 2 0.0000
911 CONTUSION 4 0.0000
912 BRONCHITIS 3 0.0000
913 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
914 ACNE 3 0.0000
915 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
916 CARDIOVASCULAR DISORDER 1 0.0000
917 COUGH 11 0.0000
918 INJECTION SITE SWELLING 3 0.0000
919 PERIPHERAL SWELLING 6 0.0000
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
921 DEAFNESS 1 0.0000
922 HYPERSENSITIVITY 7 0.0000
923 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
924 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
925 NEUTROPENIA 5 0.0000
926 CONSTIPATION 8 0.0000
927 ABNORMAL DREAMS 1 0.0000
928 COMPLETED SUICIDE 3 0.0000
929 SKIN EXFOLIATION 3 0.0000
930 CEREBROVASCULAR ACCIDENT 6 0.0000
931 DRUG WITHDRAWAL SYNDROME 3 0.0000
932 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
933 CHILLS 4 0.0000
934 SURGERY 2 0.0000
935 JOINT SWELLING 4 0.0000
936 CYSTITIS 1 0.0000
937 ARTHRALGIA 13 0.0000
938 PRURITUS 12 0.0000
939 INFUSION RELATED REACTION 2 0.0000
940 GAIT INABILITY 1 0.0000
941 EYE PRURITUS 1 0.0000
942 SINUSITIS 3 0.0000
943 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
944 HAEMORRHAGE 3 0.0000
945 CEREBRAL HAEMORRHAGE 1 0.0000
946 MOBILITY DECREASED 2 0.0000
947 C-REACTIVE PROTEIN INCREASED 1 0.0000
948 EYE SWELLING 1 0.0000
949 HYPOAESTHESIA 4 0.0000
950 HOT FLUSH 2 0.0000
951 BLOOD GLUCOSE INCREASED 5 0.0000
952 DIABETES MELLITUS 2 0.0000
953 BLOOD PRESSURE INCREASED 4 0.0000
954 PALPITATIONS 3 0.0000
955 ARTHRITIS 2 0.0000
956 DRUG DEPENDENCE 4 0.0000
957 PROSTATE CANCER 2 0.0000
958 EXTRA DOSE ADMINISTERED 1 0.0000
959 PAIN IN EXTREMITY 7 0.0000
960 MUSCULOSKELETAL STIFFNESS 2 0.0000
961 BREAST CANCER 2 0.0000
962 SWELLING 2 0.0000
963 INFECTION 3 0.0000
964 CELLULITIS 1 0.0000
965 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
966 ECZEMA 1 0.0000
967 DERMATITIS ATOPIC 1 0.0000
968 DRUG DOSE OMISSION 3 0.0000
969 HAEMATOCHEZIA 1 0.0000
970 SEPSIS 2 0.0000
971 EYE PAIN 1 0.0000
972 BONE PAIN 1 0.0000
973 EMOTIONAL DISTRESS 2 0.0000
974 DISCOMFORT 1 0.0000
975 DEEP VEIN THROMBOSIS 1 0.0000
976 DRY SKIN 2 0.0000
977 BURNING SENSATION 1 0.0000
978 CHRONIC KIDNEY DISEASE 1 0.0000
979 DRUG DOSE OMISSION BY DEVICE 1 0.0000
980 DEATH 11 0.0000
981 CARDIAC FAILURE 1 0.0000
982 DRY MOUTH 1 0.0000
983 DRUG ABUSE 1 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
985 MYALGIA 2 0.0000
986 MUSCLE SPASMS 2 0.0000
987 ATRIAL FIBRILLATION 1 0.0000
988 FLUSHING 1 0.0000
989 CHEST DISCOMFORT 1 0.0000
990 INJECTION SITE PAIN 2 0.0000